liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Alteration of the serine protease PRSS56 causes angle-closure glaucoma in mice and posterior microphthalmia in humans and mice
Howard Hughes Medical Institute, The Jackson Laboratory, Maine, USA.
Equipe Procédés de Criblages Moléculaires et Cellulaires, Laboratoire de Microorganismes et Biomolécules, Centre de Biotechnologie de Sfax, Université de Sfax, Sfax, Tunisia.
Howard Hughes Medical Institute, The Jackson Laboratory, Maine, USA.
Howard Hughes Medical Institute, The Jackson Laboratory, Maine, USA.
Show others and affiliations
2011 (English)In: NATURE GENETICS, ISSN 1061-4036, Vol. 43, no 6, 579-U118 p.Article in journal (Refereed) Published
Abstract [en]

Angle-closure glaucoma (ACG) is a subset of glaucoma affecting 16 million people(1-3). Although 4 million people are bilaterally blind from ACG(4,5), the causative molecular mechanisms of ACG remain to be defined. High intraocular pressure induces glaucoma in ACG. High intraocular pressure traditionally was suggested to result from the iris blocking or closing the angle of the eye, thereby limiting aqueous humor drainage. Eyes from individuals with ACG often have a modestly decreased axial length, shallow anterior chamber and relatively large lens, features that predispose to angle closure(6). Here we show that genetic alteration of a previously unidentified serine protease (PRSS56) alters axial length and causes a mouse phenotype resembling ACG. Mutations affecting this protease also cause a severe decrease of axial length in individuals with posterior microphthalmia. Together, these data suggest that alterations of this serine protease may contribute to a spectrum of human ocular conditions including reduced ocular size and ACG.

Place, publisher, year, edition, pages
Nature Publishing Group , 2011. Vol. 43, no 6, 579-U118 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-68902DOI: 10.1038/ng.813ISI: 000291017000017OAI: oai:DiVA.org:liu-68902DiVA: diva2:422023
Available from: 2011-06-10 Created: 2011-06-10 Last updated: 2011-06-13

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Söderkvist, Peter

Search in DiVA

By author/editor
Söderkvist, Peter
By organisation
Cell BiologyFaculty of Health Sciences
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 87 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf